{
    "Trade/Device Name(s)": [
        "EUROIMMUN ANA Screen ELISA (IgG)",
        "ANA Screen ELISA (IgG)",
        "EUROIMMUN ANA-Screen ELISA (IgG)"
    ],
    "Submitter Information": "EUROIMMUN US INC.",
    "510(k) Number": "K131185",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081104"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LJM"
    ],
    "Summary Letter Date": "April 24, 2013",
    "Summary Letter Received Date": "April 26, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5100",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Antinuclear Antibody Immunological Test System"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "Anti-nuclear antibodies (IgG)",
        "dsDNA",
        "histones",
        "ribosomal P-proteins",
        "nRNP/Sm",
        "Sm",
        "SS-A",
        "SS-B",
        "Scl-70",
        "Jo-1",
        "centromeres"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (EDTA)",
        "Plasma (Li-heparin)",
        "Plasma (Citrate)"
    ],
    "Specimen Container(s)": [
        "EDTA tube",
        "Li-heparin tube",
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Microwell plate reader (450 nm/620 nm dual wavelength)",
        "96-well microtiter plates"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)",
        "Qualitative immunoassay"
    ],
    "Methodologies": [
        "Antibody detection",
        "Enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for EUROIMMUN ANA Screen ELISA (IgG), a qualitative ELISA for IgG anti-nuclear antibody detection in serum and plasma to aid autoimmune disease diagnosis.",
    "Indications for Use Summary": "Qualitative detection of IgG antibodies to nuclear antigens in human serum and plasma as an aid in the diagnosis of mixed connective tissue diseases, systemic lupus erythematosus, Sj\u00f6gren's syndrome, progressive systemic sclerosis, and poly/dermatomyositis, in conjunction with other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}